Disrupting the residual triggers of COVID-19 in patients with long COVID SARS-CoV-2 persists in the epipharyngeal (a region behind the nasal cavity) mucosa of patients with long COVID. However, the impact of these persistent viral antigens on the epipharyngeal immune respo...

#Medsky🧪 #IDsky #immunosky #publichealth The Researchers in🇯🇵 has identified the #epipharynx, a part of the pharynx, as a 🔑 site for viral persistent & chronic inflammation driven by residual #SARSCoV2 RNA in #Longcovid patients

www.eurekalert.org/news-release...

Targeting the epipharynx to disrupt the residual triggers of COVID-19 in patients with long COVID The COVID-19 pandemic had a profound effect on the world, resulting in a dramatic loss of human lives. While the situation is now largely under control, there are patients who still suffer from the di...

#Targeting the #epipharynx to #disrupt the #residual #triggers of #COVID19 in #patients with #LongCOVID. #health #pandemic #treatment #research #Japan #science #biology #virus #viral #recovery #hidden #resevoir #RNA medicalxpress.com/news/2025-05...

@uriebay.bsky.social @beyerstein.bsky.social @tomlevenson.bsky.social @anniegirl.bsky.social @doloresquintana.bsky.social @merlinofcanada.bsky.social @maej43.bsky.social Lingering #Covid19😷 in the #epipharynx could be triggering #LongCovid